Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 152 of 152

TitleReference numberPublishedLast updated
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemiaTA1119
Delgocitinib for treating moderate to severe chronic hand eczemaTA1107
Rehabilitation for chronic neurological disorders including acquired brain injuryNG252
Chronic heart failure in adults: diagnosis and managementNG106
Chronic heart failure in adultsQS9
Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessmentHTG753
Dapagliflozin for treating chronic kidney diseaseTA1075
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentHTG748
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney diseaseTA1035
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)NG245
Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal)TA969
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedemaTA953
Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and overTA949
Empagliflozin for treating chronic kidney diseaseTA942
Middle meningeal artery embolisation for chronic subdural haematomasIPG779
Zanubrutinib for treating chronic lymphocytic leukaemiaTA931
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionTA929
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemiaIPG773
Chronic obstructive pulmonary disease in adultsQS10
Cryotherapy for chronic rhinitisIPG771
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retentionIPG766
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionTA902
Bulevirtide for treating chronic hepatitis DTA896
Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemiaTA891
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuriesIPG762
Finerenone for treating chronic kidney disease in type 2 diabetesTA877
Percutaneous image-guided cryoablation of peripheral neuroma for chronic painIPG747
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal)TA847
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal)TA840
Fostamatinib for treating refractory chronic immune thrombocytopeniaTA835
Neurostimulation of lumbar muscles for refractory non-specific chronic low back painIPG739
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)TA826
Differential target multiplexed spinal cord stimulation for chronic lower back and leg painMIB305
iFuse for treating chronic sacroiliac joint painHTG488
Superficial venous arterialisation for chronic limb threatening ischaemiaIPG736
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitorsTA813
Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal)TA811
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney diseaseTA809
Roxadustat for treating symptomatic anaemia in chronic kidney diseaseTA807
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Granulox for managing chronic non-healing woundsMIB296
Liposuction for chronic lymphoedemaIPG723
Liposuction for chronic lipoedemaIPG721
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Prontosan for treating acute and chronic woundsHTG616
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseIPG714
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureIPG711
Chronic kidney disease: assessment and managementNG203
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and managementNG206
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)TA731
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adultsIPG693
Acalabrutinib for treating chronic lymphocytic leukaemiaTA689
Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary painNG193
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA678
Dapagliflozin for treating chronic heart failure with reduced ejection fractionTA679
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to healHTG566
Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic painMIB238
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA648
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney diseaseIPG677
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing woundsMIB208
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and CHTG385
Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA617
Balloon dilation for chronic eustachian tube dysfunctionIPG665
LQD Spray for treating acute and chronic woundsMIB202
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoeaTA605
Chronic obstructive pulmonary disease in over 16s: diagnosis and managementNG115
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576
The Debrisoft monofilament debridement pad for use in acute or chronic woundsHTG334
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemiaTA561
Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosisIPG640
Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic painHTG498
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribingNG114
Eltrombopag for treating chronic immune thrombocytopeniaTA293
Romiplostim for the treatment of chronic immune thrombocytopeniaTA221
myAIRVO2 for the treatment of chronic obstructive pulmonary diseaseMIB161
Transaxial interbody lumbosacral fusion for severe chronic low back painIPG620
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis CTA507
EpiFix for chronic woundsMIB139
Glecaprevir–pibrentasvir for treating chronic hepatitis CTA499
Hepatitis B (chronic): diagnosis and managementCG165
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseIPG593
Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal)TA469
Chronic kidney disease in adultsQS5
Roflumilast for treating chronic obstructive pulmonary diseaseTA461
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal)TA452
Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemiaTA451
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysisHTG441
Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac painIPG578
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)TA435
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal)TA437
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromideES5
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutationTA429
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
XprESS multi sinus dilation system for treating chronic sinusitisHTG424
Elbasvir–grazoprevir for treating chronic hepatitis CTA413
Woundchek Protease Status for assessing elevated protease status in chronic woundsMIB83
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertensionIPG554
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fractionTA388
Chronic wounds: advanced wound dressings and antimicrobial dressingsESMPB2
Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisIPG551
Guidance on the use of imatinib for chronic myeloid leukaemiaTA70
Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retentionIPG536
Ledipasvir–sofosbuvir for treating chronic hepatitis CTA363
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis CTA365
Idelalisib for treating chronic lymphocytic leukaemiaTA359
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headacheIPG527
Omalizumab for previously treated chronic spontaneous urticariaTA339
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemiaTA343
Sofosbuvir for treating chronic hepatitis CTA330
The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney diseaseMIB12
Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic woundsMIB11
Chronic urticaria: off-label doses of cetirizineESUOM31
Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitusMIB5
The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burnsMIB1
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis CTA106
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young peopleTA300
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis CTA75
Chronic anal fissure: botulinum toxin type A injectionESUOM14
Occipital nerve stimulation for intractable chronic migraineIPG452
Peripheral nerve-field stimulation for chronic low back painIPG451
Chronic anal fissure: 0.2% topical glyceryl trinitrate ointmentESUOM7
Chronic anal fissure: 2% topical diltiazem hydrochlorideESUOM3
Ivabradine for treating chronic heart failureTA267
Botulinum toxin type A for the prevention of headaches in adults with chronic migraineTA260
Deep brain stimulation for refractory chronic pain syndromes (excluding headache)IPG382
Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemiaTA218
Bendamustine for the first-line treatment of chronic lymphocytic leukaemiaTA216
Prucalopride for the treatment of chronic constipation in womenTA211
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis CTA200
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemiaTA193
Depression in adults with a chronic physical health problem: recognition and managementCG91
Alitretinoin for the treatment of severe chronic hand eczemaTA177
Tenofovir disoproxil for the treatment of chronic hepatitis BTA173
Rituximab for the first-line treatment of chronic lymphocytic leukaemiaTA174
Spinal cord stimulation for chronic pain of neuropathic or ischaemic originTA159
Balloon catheter dilation of paranasal sinus ostia for chronic sinusitisIPG273
Entecavir for the treatment of chronic hepatitis BTA153
Telbivudine for the treatment of chronic hepatitis BTA154
Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic painIPG234
Lower limb deep vein valve reconstruction for chronic deep venous incompetenceIPG219
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemiaTA119
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis BTA96
Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemiaTA29

Results per page

  1. 10
  2. 25
  3. 50
  4. All